Pharma stocks reeled under pressure on fears that the duty entitlement passbook (DEPB) benefits scheme may be withdrawn from the exporting companies, thus, hurt their overseas formulations.
first published: May 6, 2011 02:04 pm
A collection of the most-viewed Moneycontrol videos.
You are already a Moneycontrol Pro user.